Dupilumab Phase 4 Study
NCT03411837
·
clinicaltrials.gov ↗
TERMINATED
Status
46
Enrollment
OTHER
Sponsor class
Stopped
Investigator moved from institution.
Conditions
Atopic Dermatitis
Interventions
BIOLOGICAL:
Dupilumab
Sponsor
Northwestern University